Clinical Trial Update: EPI-MINN: Targeting Cognition and Motivation - National [NA]

View source ↗

Summary

An update on the EPI-MINN trial from the University of Minnesota evaluating cognition and motivation in several psychotic disorders; the study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder with Psychotic Features
• Schizoaffective Disorder
• Schizophrenia
• Schizophrenia Spectrum and Other Psychotic Disorders
• Schizophreniform Disorder

Drugs mentioned

• EPI-MINN

Snippet

Sponsor: University of Minnesota | Conditions: Psychosis, Psychosis Nos/Other | NA | Status: ACTIVE_NOT_RECRUITING